Hayward, CA --- Biolog, Inc., a biotechnology company pioneering
sophisticated new tools for cell-based analysis, announced today
that it has launched its new filamentous fungi (FF) product line.
These products, which include proprietary software and the associated
test kit, are designed to dramatically simplify and improve the
identification and characterization of fungi.
The FF product line features the fifth database developed by Biolog,
which offers laboratories the broadest range of identification databases
commercially available. Designed for use with the Biolog MicroLog
System, the FF database can be used alongside other databases developed
by Biolog for bacteria and yeast identification. With the addition
of this database, the Biolog MicroLog System can now identify over
2,000 different taxa of bacteria, yeast, and fungi.
Fungal diseases have been a leading cause of crop failure and losses
in agriculture and food for years. Over the last two decades fungi
have also become a more serious threat to humans as infectious disease
agents. From "sick building" syndrome to disorders affecting immuno-compromised
patients, human fungal infections are on the rise. According to
the United States Centers for Disease Control & Prevention, deaths
from infectious diseases have decreased since 1980. However, deaths
from fungal infections have increased 200 percent during the same
The FF products have been developed in collaboration with two world-renowned
fungal experts: Dr. John Bissett at Agriculture & Agri-Food Canada,
and Dr. Rob Samson at the Centraalbureau Voor Schimmelcultures,
Netherlands. Originally designed for identification of fungal genera
important in environmental monitoring, food spoilage and agriculture,
the database includes strains from over 90 genera. The company is
expanding the database with other agriculturally important fungi,
and considering the addition of more clinical organisms.
According to Brian Sunkel, Biolog's marketing manager of microbiology,
"Mycologists have traditionally relied upon microscopic and macroscopic
visual methods to identify fungi. They have typically backed up
this visual interpretation with time-consuming biochemical tests
that can take several weeks. Even experts can often disagree about
species-level identifications. Our FF products provide rapid and
reproducible results, with identifications in days rather than weeks.
With our new FF products, the laboratory can obtain more rapid and
accurate results compared to traditional methods."
The FF products use Biolog's simple, yet powerful, biochemical
"fingerprinting" method first introduced for use with bacteria.
This method uses a patented carbon-source utilization chemistry
assay in a convenient MicroPlate test format. When an organism
is introduced to the wide variety of pre-selected carbon sources
in the MicroPlate, it produces a characteristic pattern or "fingerprint".
Another unique feature of the FF database software is the inclusion
of a library of microscopic and macroscopic digital photographs
of species in the database. These photographs can be automatically
reviewed as part of each test, to allow verification of identifications
with morphological criteria. Identifications are performed on the
Biolog MicroStation, which allows the user to build custom
databases. If an isolated organism is not in the system's database,
the user has the option of saving the results to a custom database
for future use. "Biolog's identification databases are taxonomically
the most current. Add to this our precision, accuracy and organism
diversity, and it seems apparent why the Biolog system is becoming
an indispensable tool for the microbiology laboratory," said Mr.
Biolog is a pioneer in the development of powerful new cellular
analysis tools for solving critical problems in pharmaceutical and
biotechnology research and development. Biolog markets its microbial
identification systems to a wide variety of laboratories worldwide.
The company has recently launched its Phenotype MicroArray
technology and OmniLog® PM System for such applications as
determining gene function, validating and optimizing drug targets,
and assessing cellular toxicology. Further information can be obtained
at the company's website, www.biolog.com.
more information contact Biolog at 510-785-2564.